# COMAR Title 10 — Maryland Department of Health

## Subtitle 34 — Board of Pharmacy

### Chapter 29 — Drug Therapy Management

#### Regulation .06 Therapy Management Contracts.

*COMAR 10.34.29.06*

A. A therapy management contract shall be signed by the:

  (1) Authorized prescriber or authorized prescribers involved in the management of the patient under a prescriber-pharmacist agreement;

  (2) Pharmacist or pharmacists involved in the management of the patient under a prescriber-pharmacist agreement; and

  (3) Patient receiving care under the therapy management contract.

B. A therapy management contract shall contain:

  (1) A list of allowable substitutions of chemically dissimilar drugs, if any;

  (2) A statement that:

    (a) None of the parties involved in the therapy management contract have been:

      (i) Coerced into participating in the therapy management contract;

      (ii) Given economic incentives, excluding normal reimbursement for services rendered; or

      (iii) Involuntarily required to participate in the therapy management contract; and

    (b) The pharmacist shall notify the authorized prescriber under the terms of the prescriber-pharmacist agreement if the pharmacist:

      (i) Modifies the dose or agent under the therapy management contract; or

      (ii) Detects an abnormal result from an assessment activity;

  (3) Notice to the patient stating:

    (a) That the patient may terminate the therapy management contract at any time; and

    (b) The procedure by which the patient may terminate the therapy management contract;

  (4) A procedure for periodic review by the authorized prescriber of the drugs modified under the prescriber-pharmacist agreement or changed with the consent of the authorized prescriber;

  (5) A reference to the protocol or protocols under which the pharmacist shall act; and

  (6) Exceptions or limitations to the protocol or protocols for the specific patient.